News

Every investor in Abbott Laboratories (NYSE:ABT) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are institutions with 80% ownership. In ...
Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company ...
We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of ...
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...
Abbott Laboratories' second-largest division, diagnostics, continues to be a hindrance, while the FY group operating margin ...
For traders who focus on events, examining the historical reactions of the stock to earnings announcements can offer useful ...
Abbott Laboratories (NYSE:ABT) stock drops as the company reported mixed Q2 2025 results and sets its Q3 guidance below ...
Importantly, Abbott Laboratories (NYSE:ABT) does carry debt. But the real question is whether this debt is making the company risky. Debt assists a business until the business has trouble paying it ...
Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Barclays from $158.00 to $159.00 in a report released on Thursday morning,Benzinga reports.
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price objective upped by equities research analysts at Morgan Stanley from $117.00 to $127.00 in a note issued to investors on Thursday ...